Ontology highlight
ABSTRACT: Objective
Despite growing expertise and wide application of venovenous extracorporeal membrane oxygenation (VV ECMO) treatment for acute respiratory distress syndrome (ARDS) of different origin and during pandemics (H1N1 Influenza A virus and SARS-CoV-2), large reports are few and pertain mostly to multicenter registries, and randomized trials are difficult to perform. The aim of this study was to report outcomes, trends, and innovations of VV ECMO treatment over the last 11 years.Design, setting, and participants
Observational study on 142 patients treated at the IRCCS San Raffaele Hospital in Milan from June 2009 (year of the H1N1 pandemic) to May 2020 (SARS-CoV-2 pandemic).Interventions
None.Measurements and main results
The main causes of ARDS were H1N1
SUBMITTER: Pieri M
PROVIDER: S-EPMC8461266 | biostudies-literature | 2022 Jun
REPOSITORIES: biostudies-literature